Stock of Interest

Posted On: October 18, 2023

#MARKSANS (NSE) Stock Report | 17 Oct 2023

Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

#xCalData predicts that # MARKSANS will continue its bullish phase over the next five days and trend within the range of 97 to 115.

In comparison to the previous month, the price of the stock has experienced an increase of 5.65% indicating a bullish.

The Stock has doubled once since 26 Mar 2015 and took an average of 0.4 years to double.

The stock has not shown seasonality trend in the past.

Reviewing the returns for the past 5 years for the same week, we see the stock has given negative returns in 3 years in the past.

Majority of the technical ratios trend towards Bullish side of the spectrum.

Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days.

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play.

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData